findmyKOL
Clinical trialNCT00059852CompletedPhase 2Interventional

Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane

SponsorAlliance for Clinical Trials in OncologyEnrollment61Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Mayo Clinic Scottsdale Oncology Program

    Scottsdale, Arizona, United States

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida, United States

  • Ccop - Illinois Oncology Research Association

    Peoria, Illinois, United States

  • Ccop - Carle Cancer Center

    Urbana, Illinois, United States

  • Ccop - Cedar Rapids Oncology Project

    Cedar Rapids, Iowa, United States

  • Ccop - Iowa Oncology Research Association

    Des Moines, Iowa, United States

  • Siouxland Hematology-Oncology

    Sioux City, Iowa, United States

  • Ccop - Wichita

    Wichita, Kansas, United States

  • Ccop - Ochsner

    New Orleans, Louisiana, United States

  • Ccop - Michigan Cancer Research Consortium

    Ann Arbor, Michigan, United States

  • Ccop - Duluth

    Duluth, Minnesota, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Centracare Health Plaza

    Saint Cloud, Minnesota, United States

  • Ccop - Metro-Minnesota

    Saint Louis Park, Minnesota, United States

  • Ccop - Missouri Valley Cancer Consortium

    Omaha, Nebraska, United States

  • Medcenter One Health System

    Bismarck, North Dakota, United States

  • Ccop - Merit Care Hospital

    Fargo, North Dakota, United States

  • Ccop - Dayton

    Dayton, Ohio, United States

  • Ccop - Toledo Community Hospital

    Toledo, Ohio, United States

  • Ccop - Oklahoma

    Tulsa, Oklahoma, United States

  • Ccop - Geisinger Clinic and Medical Center

    Danville, Pennsylvania, United States

  • Ccop - Upstate Carolina

    Spartanburg, South Carolina, United States

  • Rapid City Regional Hospital

    Rapid City, South Dakota, United States

  • Ccop - Sioux Community Cancer Consortium

    Sioux Falls, South Dakota, United States

  • Ccop - St. Vincent Hospital Cancer Center, Green Bay

    Green Bay, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2003
Primary completion
31 Aug 2006
Completion
31 Jan 2009
Last update posted
7 Dec 2016
Registered enrollment
61
Registry id
NCT00059852

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.